ArticleAnais brasileiros de dermatologia

Mid-term effectiveness, safety, and potential predictors of response of upadacitinib in patients with moderate-to-severe atopic dermatitis: a multicenter observational retrospective study.

Francisco Javier Melgosa Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.